Previous studies have shown that individuals with newly diagnosed systemic lupus erythematosus (SLE) have an increased risk of pulmonary complications. However, these analyses did not consistently account for potential confounding variables. Recent evidence highlights the importance of routine pulmonary screening and emphasizes the need to take a proactive approach to the management of pulmonary problems in this patient group.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Benralizumab in a patient with asthma and EGPA
When the biologic has a counterproductive effect
- Brain atrophy and MS
Brain atrophy correlates with disability progression in MS
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Diabetes mellitus
Treatment of comorbidities in older people
- Pulmonary sarcoidosis
Prednisone vs. MTX: a draw after 24 weeks
- Friedreich's ataxia
Loss of orientation in the cerebellum
- Diabetes mellitus